Cytokine and Protein Biomarker Assay Services
Concentration of specific proteins in blood and tissue may help assess immune activity and drug-mediated responses, understand inflammatory response pathways or disease presence and progression, and ultimately guide decision-making in a novel therapeutic program.
To detect and measure these protein biomarkers, immunoassays are widely used in clinical research. At Precision, we develop and customize each immunoassay based on project requirements and factors such as desired sensitivity, the need to multiplex, and available sample volume.
Cytokine and protein analysis delivered via an array of technologies
-
Explore
Luminex®
Luminex is useful when multiplexed measurements at high sensitivity, even in complex matrices, are needed. We generally utilize the Luminex platform in early phase studies profiling cytokines and other analytes. -
Explore
Olink Proteomics
High-multiplex quantification of protein biomarkers with minimal clinical sample volume and exceptional sensitivity and specificity -
Explore
Meso Scale Discovery (MSD)
Measuring a range of analytes in complex sample matrices consistently and at high sensitivity, with applications including ADA, NAb, TAb, and PK assays -
Explore
Western blotting
Providing western blotting via automated platforms to ensure accurate, reproducible results -
Explore
ELISA
Services using the gold standard for quantitative antibody-based bioanalysis, with specialization in immunogenicity assay development
Solutions for any sensitivity or multiplex needs
Luminex | Olink Proteomics | Meso Scale Discovery (MSD) | Jess Automated Western Blotting | ELISA |
|
---|---|---|---|---|---|
Sensivity |
pg/mL |
pg/mL |
pg/mL |
Low pg |
ng/mL – pg/mL |
Dynamic Range |
>4 logs |
3-4 logs |
>4 logs |
3-4 logs |
2 logs |
Multiplex Capabilities |
50-100 |
45/92 |
10 |
1-3 |
1 |
Sample Volume |
50 µL |
1 µL |
25 µL |
3 µL |
50 – 100 µL |
Use |
Early stages |
All stages |
All stages |
All stages |
All stages |
Explore related resources
Combine and analyze biomarker and clinical trial data
To help researchers understand and interpret biomarker assay data in the context of other assays and their clinical trial data, Precision provides our proprietary QuartzBio® Translational Informatics platform for managing and analyzing multidimensional data.
Collaborate with us for a personalized plan
Precision’s scientists take a collaborative approach to projects and can provide recommendations on assay strategies and implementation, if needed. Services can be provided individually or as part of a comprehensive therapeutic development package including biomarker assays and clinical trials.
Build on your research with related specialty lab services
-
Explore
Tissue Biopsy Analysis
Obtain a detailed molecular view into patient biology with a range of tissue analysis technologies and leverage our board-certified pathologists and assay development expertise -
Explore
Genomics
Find and monitor gene expression signatures, copy number variations, chromosome rearrangements, and other genomic events occurring in patient samples using our NGS, NanoString, qPCR, ddPCR, and FISH/ISH services. -
Explore
Bioanalytical Testing
Get bioanalytical support for your biologic, cell therapy, gene therapy, or companion diagnostics program from the globally recognized leaders in immunogenicity testing.